Alucent Medical, Inc.

Alucent Medical, Inc., is a privately held biotech company headquartered in Salt Lake City. Alucent Medical, Inc., is licensed to develop and market Natural Vascular Scaffolding (NVS) for peripheral vascular disease (PVD). PVD is a condition that occurs when fatty deposits and calcium (plaque) build up in the walls of the arteries, causing the arteries to narrow and decrease blood circulation to the legs. We are conducting Phase 1 human clinical trials for our lead product which uses Natural Vascular Scaffolding technology to open diseased arteries and re-establish normal blood flow in these vessels. Alucent’s technology, a major advancement in the treatment of peripheral vascular disease, has the potential to eliminate the need for vascular implants and stents and could greatly reduce the need for retreatment.

NVS was developed by Alumend, LLC, a research and development company owned by Avera Health. NVS is the invention of Ron Utecht, PhD.



Latest news and events

May 12, 2017

Avera Names Myles Greenberg, MD, as CEO of Alucent Medical

SIOUX FALLS, S.D. (May 10, 2017) – Myles D. Greenberg, MD, was named President and CEO of Alucent Medical, Inc., a new company licensed to develop […]
February 27, 2017

Alucent Medical Receives FDA Approval to Begin Clinical Trials of Novel Therapy for Vascular Disease

Alucent Medical Receives FDA Approval to Begin Clinical Trials of Novel Therapy for Vascular Disease SALT LAKE CITY (May 16, 2017) – Alucent Medical, Inc., has […]

NVS has the potential to leap-frog current treatments for vascular disease.



- Dr. Krishna Rocha-Singh